Cardiac catheter pairs light, ultrasound to measure plaques

Oct. 13, 2017
The catheter can retrieve structural and biochemical information about arterial plaque to more reliably predict heart attacks.

A team of researchers at the University of California - Davis (UC Davis) has combined intravascular ultrasound (IVUS) with fluorescence lifetime imaging (FLIm) in a single catheter probe that can image the tiny arteries of a living heart. The new catheter can simultaneously retrieve structural and biochemical information about arterial plaque, with the goal of being able to more reliably predict heart attacks.

Related: Fluorescence 'lifetime' moves toward clinical application

Developed in Professor Laura Marcu's lab in the Department of Biomedical Engineering at UC Davis, the catheter features an optical fiber that sends short laser pulses into surrounding tissue, which fluoresces with tiny flashes of light in return. Different kinds of tissue (collagen, proteins, lipids) emit different amounts of fluorescence. At the same time, an ultrasound probe in the catheter records structural information about the blood vessel.

Biomedical engineers at UC Davis have combined intravascular ultrasound with fluorescence lifetime imaging in a single catheter probe that can image the tiny arteries of a living heart. The new catheter can simultaneously retrieve structural and biochemical information about arterial plaque that could more reliably predict heart attacks. (Image credit: Marcu Lab/UC Davis)

The combination FLIm-IVUS imaging catheter provides a comprehensive insight into how atherosclerotic plaque forms, aiding diagnosis and providing a way to measure how plaques shrink in response to therapy.

The catheter, which has been tested in living swine hearts and samples of human coronary arteries, is flexible enough to access coronary arteries in a living human following standard procedures. It does not require any injected fluorescent tracers or any special modification of the catheterization procedures.

The new technique could not only can improve understanding of mechanisms behind plaque rupture—an event with fatal consequences—but also the diagnosis and treatment of patients with heart disease.

Marcu's group is currently working to obtain FDA approval to test this new intravascular technology on human patients.

Full details of the work appear in the journal Scientific Reports.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

LASEROPTIK GmbH honored with TRUMPF Supplier Award

Nov. 17, 2023
LASEROPTIK GmbH was honored with the TRUMPF Supplier Award in the ”Best Innovator” category at the TRUMPF Supplier Day. The laudatory speech highlighted in particular...

Determining Density of H2O2 Using Absorption Spectroscopy in Plasma Jets

Nov. 17, 2023
Biomedically relevant species can be utilized in custom compositions for medical, industrial or agricultural applications. Studying H2O2 densities with cavity ring-down spectroscopy...

Video: November 17, 2023 Photonics Hot List

Nov. 17, 2023
In this episode, we cover a solar device that makes dirty water clean, dual-frequency combs that hit record speeds, and how quantum light can 'hear' sounds in molecules.

Microspectrophotometer is configurable with Raman spectroscopy

Nov. 17, 2023
The FLEX PRO microspectrophotometer combines UV-VIS-NIR microspectroscopy and imaging for flexible and precise measurement of samples.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!